{"id":23358,"date":"2025-04-13T17:39:37","date_gmt":"2025-04-13T17:39:37","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23358"},"modified":"2025-10-23T01:15:38","modified_gmt":"2025-10-23T01:15:38","slug":"dmxe-40-mg-pellets-deoximetoxetamin","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/sv\/produkt\/dmxe-40-mg-pellets-deoximetoxetamin\/","title":{"rendered":"DMXE 40 mg pellets (deoximetoxetamin)"},"content":{"rendered":"

DMXE (Deoximetoxetamin) 40 mg pellets \u2013 Vetenskaplig produktdokumentation<\/span><\/span><\/strong><\/h3>\n

\ud83d\udd2cKemiska specifikationer<\/span><\/span><\/strong><\/h4>\n

DMXE (2\u2032-Oxo-PCE-d10) \u00e4r en forskningskemikalie som tillh\u00f6r arylcyklohexylaminklassen, strukturellt besl\u00e4ktad med MXE (metoxetamin) och ketamin. Dessa pellets \u00e4r formulerade f\u00f6r precis vetenskaplig forskning.<\/span><\/span><\/p>\n

K\u00e4rnparametrar:<\/span><\/span><\/em><\/p>\n

    \n
  • \n

    IUPAC-namn<\/span><\/span><\/strong> 2-(3,4-dimetylfenyl)-2-(etylamino)cyklohexanon<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Molekylformel<\/span><\/span><\/strong> : C\u2081\u2086H\u2082\u2083NO<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Molekylvikt<\/span><\/span><\/strong> : 245,36 g\/mol<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Renhet<\/span><\/span><\/strong> : \u226598% (GC-MS-analys)<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Form<\/span><\/span><\/strong> Runda pellets med 4 mm diameter<\/span><\/span><\/p>\n<\/li>\n

  • \n

    F\u00e4rg<\/span><\/span><\/strong> Ljusbeige till vit<\/span><\/span><\/p>\n<\/li>\n

  • \n

    L\u00f6slighet<\/span><\/span><\/strong> 15 mg\/ml i vatten (vid 25\u00b0C)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

    \ud83e\uddeaVetenskapliga till\u00e4mpningar<\/span><\/span><\/strong><\/h4>\n
      \n
    1. \n

      Neurofarmakologisk forskning<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

        \n
      • \n

        Studier av NMDA-receptorantagonism<\/span><\/span><\/p>\n<\/li>\n

      • \n

        Sigma-1-receptorinteraktionsanalyser<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

      • \n

        Beteendem\u00e4ssig neurovetenskap<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

          \n
        • \n

          Effekter p\u00e5 inl\u00e4rningsbeteende hos f\u00f6rs\u00f6ksdjur<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Dosberoende dissociativa effekter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

        • \n

          Psykofarmaka<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

            \n
          • \n

            J\u00e4mf\u00f6rande studier med relaterade dissociativa<\/span><\/span><\/p>\n<\/li>\n

          • \n

            Forskning om neuroplastiska effekter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

            \u2696\ufe0fRekommenderade forskningsprotokoll<\/span><\/span><\/strong><\/h4>\n

            Experimentella riktlinjer:<\/span><\/span><\/em><\/p>\n

            \n\n\n\n\n\n\n\n
            Modell<\/span><\/span><\/th>\nDosering<\/span><\/span><\/th>\nFrekvens<\/span><\/span><\/th>\n<\/tr>\n<\/thead>\n
            In vitro<\/span><\/span><\/td>\n10\u201350 \u03bcM<\/span><\/span><\/td>\nEnskild exponering<\/span><\/span><\/td>\n<\/tr>\n
            Sm\u00e5 gnagare<\/span><\/span><\/td>\n5\u201320 mg\/kg<\/span><\/span><\/td>\n1x\/dag (max 3 dagar)<\/span><\/span><\/td>\n<\/tr>\n
            Primater<\/span><\/span><\/td>\n1\u20135 mg\/kg<\/span><\/span><\/td>\nEng\u00e5ngsdos<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

            *Obs: Icke-linj\u00e4r farmakokinetik \u00f6ver 25 mg\/kg*<\/span><\/span><\/p>\n

            \u26a0\ufe0fS\u00e4kerhetsprofil och riskhantering<\/span><\/span><\/strong><\/h4>\n
              \n
            1. \n

              Toxikologiska data<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                \n
              • \n

                LD\u2085\u2080 (r\u00e5tta, oral): 320 mg\/kg<\/span><\/span><\/p>\n<\/li>\n

              • \n

                NOAEL: 5 mg\/kg\/dag (7-dagarsstudie)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

              • \n

                Biverkningsspektrum<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                  \n
                • \n

                  <10 mg: Subtila beteendeeffekter<\/span><\/span><\/p>\n<\/li>\n

                • \n

                  10\u201330 mg: Motorisk inkoordination<\/span><\/span><\/p>\n<\/li>\n

                • \n
                  \n

                  30 mg: Potentiell andningsdepression<\/span><\/span><\/p>\n<\/blockquote>\n<\/li>\n<\/ul>\n<\/li>\n

                • \n

                  Kritiska interaktioner<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                    \n
                  • \n

                    Farlig<\/span><\/span><\/strong> Opioider, GABA-erga l\u00e4kemedel<\/span><\/span><\/p>\n<\/li>\n

                  • \n

                    Riskabel<\/span><\/span><\/strong> Stimulantia, MAO-h\u00e4mmare<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

                    \ud83d\udccaKvalitetskontroll och analytiska data<\/span><\/span><\/strong><\/h4>\n
                      \n
                    • \n

                      HPLC-renhet<\/span><\/span><\/strong> 98,5% (C18-kolonn, 70:30 H\u2082O:MeCN)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      Enhetlighet<\/span><\/span><\/strong> \u00b15% viktavvikelse (n=20 pellets)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      S\u00f6nderfallstid<\/span><\/span><\/strong> <15 minuter (i samtidig magsaft)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      Stabilitetsdata<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                        \n
                      • \n

                        H\u00e5llbarhet: 24 m\u00e5nader vid 15\u201325 \u00b0C<\/span><\/span><\/p>\n<\/li>\n

                      • \n

                        Fuktk\u00e4nslighet: <0,5% vikt\u00f6kning (93% RH)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

                        \u2753Vanliga forskningsfr\u00e5gor<\/span><\/span><\/strong><\/h4>\n

                        F1: Vad \u00e4r verkningsmekanismen?<\/span><\/span><\/strong>
                        \n A: Prim\u00e4r NMDA-receptorantagonism med sekund\u00e4r dopamin\u00e5terupptagsh\u00e4mning.<\/span><\/span><\/p>\n

                        F2: Hur st\u00e5r sig styrkan i j\u00e4mf\u00f6relse med ketamin?<\/span><\/span><\/strong>
                        \n A: ~0,6 g\u00e5nger ketamins styrka men l\u00e4ngre halveringstid (4\u20136 timmar).<\/span><\/span><\/p>\n

                        F3: Finns det neurotoxiska risker?<\/span><\/span><\/strong>
                        \n A: Olneys lesioner observerades inte vid <50 mg\/kg (r\u00e5ttstudie).<\/span><\/span><\/p>\n

                        F4: Vilken \u00e4r den optimala f\u00f6rvaringsmetoden?<\/span><\/span><\/strong>
                        \n A: I originalf\u00f6rpackningen vid 15\u201325 \u00b0C, skyddad fr\u00e5n fukt.<\/span><\/span><\/p>\n

                        \ud83d\udcccForskningens begr\u00e4nsningar<\/span><\/span><\/strong><\/h4>\n
                          \n
                        • \n

                          Begr\u00e4nsade data om kronisk administrering<\/span><\/span><\/p>\n<\/li>\n

                        • \n

                          Ok\u00e4nda effekter p\u00e5 glutamat\u00f6verf\u00f6ring<\/span><\/span><\/p>\n<\/li>\n

                        • \n

                          Variabel biotransformation mellan arter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                          \ud83d\udd0dSlutsats f\u00f6r forskare<\/span><\/span><\/strong><\/h4>\n

                          DMXE 40 mg pellets erbjuder en standardiserad formulering f\u00f6r exakt dissociativ forskning, med konsekvent dosleverans och god stabilitet. Pelletformen underl\u00e4ttar kvantitativ administrering i djurstudier.<\/span><\/span><\/p>\n

                          Vetenskaplig ansvarsfriskrivning: Denna produkt \u00e4r endast avsedd f\u00f6r in vitro-forskning och auktoriserade prekliniska studier. Ej f\u00f6r m\u00e4nsklig anv\u00e4ndning. Alla experiment m\u00e5ste f\u00f6lja g\u00e4llande etiska riktlinjer och lokala f\u00f6reskrifter. V\u00e4nligen observera den s\u00e4rskilda statusen f\u00f6r psykoaktiva forskningssubstanser i din jurisdiktion.<\/span><\/span><\/em><\/p>","protected":false},"excerpt":{"rendered":"

                          DMXE-funktioner<\/span><\/span><\/span><\/span><\/h3>\n

                          Synonym:<\/span><\/span><\/span><\/span><\/strong> Deoximetoxetaminhydroklorid <\/span><\/span><\/span><\/span>
                          \nCAS-nummer:<\/span><\/span><\/span><\/span><\/strong> 681440-83-5 <\/span><\/span><\/span><\/span>
                          \nFormel:<\/span><\/span><\/span><\/span><\/strong> 5-dehydro-1,3-kinodimetan <\/span><\/span><\/span><\/span>
                          \nMolmassa:<\/span><\/span><\/span><\/span><\/strong> 103,14 g\/mol <\/span><\/span><\/span><\/span>
                          \nRenhet:<\/span><\/span><\/span><\/span><\/strong> >97%<\/span><\/span><\/span><\/span><\/p>","protected":false},"featured_media":28769,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[71,406,429,324],"product_tag":[326],"class_list":["post-23358","product","type-product","status-publish","has-post-thumbnail","product_cat-arylcyclohexylamine","product_cat-dmxe","product_cat-dmxe-pellets","product_cat-pellets-for-pellet","product_tag-nl","first","instock","taxable","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product\/23358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/comments?post=23358"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product\/23358\/revisions"}],"predecessor-version":[{"id":28083,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product\/23358\/revisions\/28083"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/media\/28769"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/media?parent=23358"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product_brand?post=23358"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product_cat?post=23358"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/sv\/wp-json\/wp\/v2\/product_tag?post=23358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}